U.S. Paper and Forestry Products Stock News

NasdaqGS:TSAT
NasdaqGS:TSATTelecom

Telesat Faces Going Concern Flag While Targeting Defense-Focused Lightspeed Growth

Telesat (NasdaqGS:TSAT) disclosed that its auditor raised substantial doubt about the company’s ability to continue as a going concern in its latest Form 20-F filing. The company also announced plans to add military Ka-band spectrum to its Lightspeed low Earth orbit satellite constellation to support defense requirements. Both developments point to rising pressure on Telesat’s funding profile alongside a clearer push toward government and defense users. Telesat operates in satellite...
NasdaqGM:BZAI
NasdaqGM:BZAISemiconductor

Blaize Holdings (BZAI) Revenue Surge Challenges Cautious Narratives Around Ongoing Losses

Setting the scene: Blaize Holdings's FY 2025 earnings snapshot Blaize Holdings (BZAI) just closed FY 2025 with fourth quarter revenue of US$23.8 million and basic EPS of US$0.03 loss, against trailing twelve month revenue of US$38.6 million and EPS of US$1.98 loss, alongside very large reported year over year revenue growth of 2,386%. The company has seen quarterly revenue move from US$0.001 million in Q4 FY 2024 to US$23.8 million in Q4 FY 2025. Over that span, EPS has ranged from US$1.61...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

AI Agents Test Manhattan Associates’ Moat And Valuation Story

AI powered autonomous agents such as Anthropic's Claude are emerging as cross platform tools that can handle complex workflows typically managed by enterprise software. Investors are starting to question how this could affect the role of traditional application layer providers, including Manhattan Associates (NasdaqGS:MANH), particularly around pricing power and profitability. This development has recently drawn more attention, yet it has not been a core focus of recent coverage that...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Cintas (CTAS) Q3 2026 Net Margin Holds At 17.5% Reinforcing Bullish Narratives

Q3 2026 Earnings Snapshot Cintas (CTAS) has just reported Q3 2026 results with quarterly revenue of about US$2.8b and basic EPS of US$1.23, giving investors a fresh read on how the business is tracking this year. Over recent quarters the company has seen revenue move from US$2.50b in Q1 2025 to US$2.80b in Q2 2026, while basic EPS has shifted from US$1.12 to US$1.23, with trailing twelve month net profit margins around 17.5% helping to frame the quality of those earnings. See our full...
NasdaqGM:EPSN
NasdaqGM:EPSNOil and Gas

Epsilon Energy (EPSN) Margin Compression Reinforces Bearish Valuation Narrative After FY 2025 Results

Epsilon Energy (EPSN) has just posted its FY 2025 numbers with third quarter revenue of about US$9.0 million and basic EPS of US$0.05, set against trailing twelve month revenue of US$45.7 million and EPS of US$0.27 that came alongside 11.2% earnings growth and a trailing net margin of 12.9% compared with 17% a year earlier. Over recent quarters the company has seen revenue move from US$7.3 million in Q2 2024 to US$16.2 million in Q1 2025, then to US$9.0 million in Q3 2025. Quarterly EPS has...
OTCPK:BSEM
OTCPK:BSEMPharmaceuticals

BioStem Governance And Hospital Expansion Moves Shape Investor Focus

BioStem Technologies (OTCPK:BSEM) appointed Jodi Ungrodt as a new member of its Board of Directors and Chair of the Audit Committee. The company completed the acquisition of BioTissue Holdings Inc.'s surgical and wound assets, including a national sales force. The transaction expands BioStem's commercial reach into hospital settings and broadens its product portfolio. BioStem Technologies, trading at $4.92, sits at an interesting point in its share price history, with a 25.9% return year to...
OTCPK:GLAS.F
OTCPK:GLAS.FPersonal Products

Glass House Brands (OTCPK:GLAS.F) Q3 Loss Renews Doubts On Path To Sustainable Profitability

Glass House Brands (OTCPK:GLAS.F) has just posted a mixed FY 2025 picture, with Q3 revenue of US$38.4 million and a basic EPS loss of US$0.19, set against trailing 12 month revenue of US$196.2 million and a basic EPS loss of US$0.23. Over recent quarters, the company has seen revenue range from US$53.0 million in Q4 2024 to US$59.9 million in Q2 2025, while basic EPS has swung between a profit of US$0.10 in Q4 2024 and a loss of US$0.19 in Q3 2025. This keeps the focus firmly on how...
NYSE:INSP
NYSE:INSPMedical Equipment

Inspire Medical Systems Governance Vote Arrives As Shares Trade Below Targets

Inspire Medical Systems (NYSE:INSP) has put forward a proposal to amend its Certificate of Incorporation. Shareholders are scheduled to vote on the amendment at the upcoming annual general meeting. The change targets the company’s core governance framework, which may influence how future decisions are approved and overseen. The vote comes at a time when Inspire Medical Systems shares trade around $51.41, with returns showing an 8.8% decline over the past week and 11.8% over the past month...
NasdaqCM:VELO
NasdaqCM:VELOMachinery

Velo3D (VELO) Quarterly Loss Of US$11.8 Million Tests Bullish Profitability Narratives

Velo3D (VELO) has released its latest FY 2025 figures, reporting Q3 revenue of US$13.6 million and a basic EPS loss of US$0.69, alongside net income excluding extra items of a US$11.8 million loss. This keeps the focus firmly on profitability rather than the top line alone. Over recent quarters, the company’s revenue moved from US$8.2 million in Q3 2024 to US$13.6 million in Q3 2025, while basic EPS shifted from a loss of US$37.54 to a loss of US$0.69 as net losses moved from US$23.1 million...
NasdaqGM:FOCL
NasdaqGM:FOCLMedical Equipment

Persistent €19.6 Million Annual Loss Tests EDAP TMS (NasdaqGM:EDAP) Growth Narrative After Q3 Results

EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Paysign (PAYS) Margin Expansion To 9.2% Reinforces Bullish Quality Narrative

Paysign (PAYS) has wrapped up FY 2025 with fourth quarter revenue of about US$22.8 million and basic EPS of US$0.02, set against trailing twelve month revenue of US$82.0 million and EPS of US$0.14 that follows reported earnings growth of 97.9% over the past year. The company has seen revenue move from US$56.5 million on a trailing basis in Q3 2024 to US$82.0 million by Q4 2025, while trailing EPS has shifted from US$0.15 to US$0.14. This sets up a story where investors are weighing 20.3%...
NasdaqGS:RRR
NasdaqGS:RRRHospitality

Is It Time To Reconsider Red Rock Resorts (RRR) After Recent Share Price Weakness

Wondering if Red Rock Resorts at around US$58.74 is offering good value right now, or if most of the upside is already priced in. The stock is roughly flat over the last week with a 0.4% decline, softer over the past month with an 8.2% decline and year to date is down 6.7%. Over the past year it has returned 38.9% and over five years 125.5%. Recent coverage has focused on how Red Rock Resorts fits into broader casino and local gaming trends, with attention on how its Las Vegas centric...
NYSE:POR
NYSE:PORElectric Utilities

Portland General Electric Expands Debt Capacity For PacifiCorp Asset Acquisition

Portland General Electric (NYSE:POR) has entered into two unsecured credit agreements that together provide access to more than $1b in new debt financing. The company plans to use the funds for capital projects and to acquire PacifiCorp’s electric transmission, distribution, and generation assets in Washington. These agreements introduce new funding structures, covenants, and timelines tied directly to this planned asset purchase. Portland General Electric, trading at $51.49, is pursuing a...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Ondas (ONDS) Quarterly Loss Narrows To US$8.8 Million Challenging Bearish Profitability Narratives

Ondas FY 2025 results set the stage for a tighter focus on profitability Ondas (ONDS) just posted its FY 2025 numbers with third quarter revenue at about US$10.1 million and a basic EPS loss of US$0.03, alongside trailing twelve month revenue of roughly US$24.7 million and a cumulative net loss of about US$47.7 million. Over recent quarters, the company has seen revenue move from around US$0.96 million in Q2 2024 to US$1.48 million in Q3 2024, then to US$4.25 million in Q1 2025, US$6.27...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

US High Growth Tech Stocks to Watch Now

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings expected to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability, positioning themselves well amidst fluctuating market conditions.
NasdaqCM:XPEL
NasdaqCM:XPELAuto Components

US Market's Top 3 Undiscovered Gems With Strong Potential

Over the last 7 days, the United States market has experienced a slight decline of 2.3%, although it has shown resilience with a 13% rise over the past year and an optimistic forecast of 16% annual earnings growth. In this dynamic environment, identifying stocks with strong potential often involves looking beyond well-known names to find those undiscovered gems that align with current growth trends and market conditions.
NYSE:FITB
NYSE:FITBBanks

3 Reliable Dividend Stocks Offering Up To 3.7% Yield

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In such a dynamic environment, selecting dividend stocks with reliable yields can provide stability and income potential for investors seeking to navigate market fluctuations.
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Is Safety Insurance Group (SAFT) Fairly Priced After Recent Share Price Softness?

Wondering whether Safety Insurance Group at around US$73.39 is a sensible entry or hold for you right now? This article focuses squarely on what the current price might imply about value. The stock has been fairly steady in the very short term with a 0.8% return over the last week. The past month shows a 6.4% decline and the year-to-date return sits at a 3.1% decline, alongside a 1.7% decline over the past year, a 14.6% return over three years and a 7.8% return over five years. Recent...
NYSE:HLIO
NYSE:HLIOMachinery

Is It Too Late To Consider Helios Technologies (HLIO) After Its 98% One Year Surge?

If you are wondering whether Helios Technologies at around US$67.54 is still attractively priced after a big run, the key question is what you are really paying for today. The stock has moved 4.0% over the last 7 days, sits on a year to date return of 23.5%, and has delivered 98.3% over the last year, although the past 30 days show a 9.0% decline that may have shifted perceptions of risk and opportunity. Recent coverage around Helios Technologies has focused on how its share price...
NasdaqGM:MDB
NasdaqGM:MDBIT

MongoDB Names New CRO To Sharpen AI And Cloud Revenue Execution

MongoDB (NasdaqGM:MDB) has appointed Ryan Mac Ban as Chief Revenue Officer. The new CRO is tasked with driving the next phase of growth in AI and cloud data markets. This leadership change follows other recent executive additions at the company. For investors watching MongoDB, the new CRO role sits at the center of how the company turns demand for AI and multi cloud data platforms into actual revenue. MongoDB focuses on modern database and developer data tools that are widely used in cloud...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

Is Ocugen (OCGN) Pricing Make Sense After Its Volatile Multi‑Year Share Price Swings

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...